Sep 05 2025 This Week in Cardiology

Sep 05 2025 This Week in Cardiology

The big beta-blocker story from ESC, dual pathway therapy with aspirin and OAC, stopping OAC after successful AF ablation, and DANCAVAS II trial are the topics John Mandrola, MD, discusses on this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I Listener Feedback

This Week in Cardiology Podcast – August 29 https://www.medscape.com/viewarticle/1002877

II The Big Beta-blocker Story from ESC

Beta-Blockers Post-MI: A Clear Clinical Message https://www.medscape.com/viewarticle/beta-blockers-post-mi-clear-clinical-message-2025a1000mz0

  • REBOOT https://www.nejm.org/doi/full/10.1056/NEJMoa2504735
  • BETAMI-DANBLOCK https://www.nejm.org/doi/abs/10.1056/NEJMoa2505985
  • REDUCE AMI https://www.nejm.org/doi/10.1056/NEJMoa2401479
  • CAPITAL RCT https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199347
  • Post Hoc Analysis From REBOOT Trial https://eurointervention.pcronline.com/article/effect-of-beta-blocker-withholding-or-withdrawal-after-myocardial-infarction-without-reduced-ejection-fraction-on-ischaemic-events-a-post-hoc-analysis-from-the-reboot-trial
  • Beta-Blockers After MI With Mildly Reduced Ejection Fraction https://doi.org/10.1016/S0140-6736(25)01592-2
  • CAPRICORN 10.1016/S0140-6736(00)04560-8 External Link
  • BHAT https://jamanetwork.com/journals/jama/fullarticle/370103
  • ISIS 1 https://pubmed.ncbi.nlm.nih.gov/2873379/

III Aspirin and OAC Combination Clearly Dangerous

Aspirin Plus Oral Anticoagulants Raises Mortality, Bleeding https://www.medscape.com/viewarticle/aspirin-plus-oral-anticoagulants-raises-mortality-bleeding-2025a1000nam

  • AQUATIC https://www.nejm.org/doi/full/10.1056/NEJMoa2507532
  • AFIRE https://www.nejm.org/doi/full/10.1056/NEJMoa1904143
  • EPIC CAD https://www.nejm.org/doi/10.1056/NEJMoa2407362
  • OAC-ALONE https://pubmed.ncbi.nlm.nih.gov/30586700/

IV Stop or Continue OAC after Successful AF Ablation

  • ALONE-AF https://jamanetwork.com/journals/jama/fullarticle/2838294
  • OCEAN trial protocol https://doi.org/10.1016/j.ahj.2017.12.007

V DANCAVAS II Trial

  • DANCAVAS II https://doi.org/10.1093/eurheartj/ehaf704
  • DANCAVAS I https://www.nejm.org/doi/full/10.1056/NEJMoa2208681

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Episoder(397)

Jan 24 2025 This Week in Cardiology

Jan 24 2025 This Week in Cardiology

Familial hypercholesterolemia, cardiac arrest therapy, Factor XI inhibition, and tricuspid valve interventions are the topics John Mandroa, MD, discusses in this week's podcast. This podcast is intend...

24 Jan 202525min

Jan 17 2025 This Week in Cardiology

Jan 17 2025 This Week in Cardiology

Renal denervation, the obesity paradox, JACC and the FINEARTS trial of finerenone in HFpEF, a setback for a PFA system, and coffee are the topics Jon Mandrola, MD, covers this week. This podcast is in...

17 Jan 202531min

Jan 10 2025 This Week in Cardiology

Jan 10 2025 This Week in Cardiology

Alcohol and cancer, GLP-1 trial representativeness, diagnosing CAD, changing stroke rates in patients with AF, blanking periods after AF ablation are the topics John Mandrola, MD, covers this week. Th...

10 Jan 202530min

Dec 20 2024 This Week in Cardiology

Dec 20 2024 This Week in Cardiology

Listener feedback, multiple studies in AF ablation, a DANISH trial substudy of ICDs in NICM, and more data on eye complications of GLP-1 agonists are the topics John Mandrola, MD, covers in this week'...

20 Des 202436min

Dec 13 2024 This Week in Cardiology

Dec 13 2024 This Week in Cardiology

US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers thi...

13 Des 202429min

Dec 06 2024 This Week in Cardiology

Dec 06 2024 This Week in Cardiology

Tirzepatide vs semaglutide in obesity; GLP1a use is complicated; HF outcomes; the misuse of meta-analyses in HF; and a breakthrough in HF care are the topics John Mandrola, MD, covers this week. This ...

6 Des 202427min

Nov 22 2024 This Week in Cardiology

Nov 22 2024 This Week in Cardiology

An AHA review: the OPTION, SUMMIT, VANISH 2, SARAH, and CLEAR trials are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To ...

22 Nov 202432min

Nov 15 2024 This Week in Cardiology

Nov 15 2024 This Week in Cardiology

Tirzepatide, AF screening, and an AHA preview, including VT ablation, LAAC at the time of AF ablation, BP targets, and GLP1 agonists in HF are the topics John Mandrola, MD, covers in today's podcast. ...

15 Nov 202428min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rss-nysgjerrige-norge
rekommandert
liberal-halvtime
forskningno
sinnsyn
rss-rekommandert
fjellsportpodden
smart-forklart
vett-og-vitenskap-med-gaute-einevoll
jss
villmarksliv
hva-er-greia-med
rss-overskuddsliv
rss-radium
dekodet-2
rss-inn-til-kjernen-med-sunniva-rose
tidlose-historier
aldring-og-helse-podden